97 related articles for article (PubMed ID: 15960425)
1. Structure-activity relationship study of some triazolinone based compounds with antagonistic balanced activity on angiotensin II receptor subtypes AT1 and AT2. A three-dimensional quantitative structure-activity relationship investigation.
Pandya T; Chaturvedi SC
Arzneimittelforschung; 2005; 55(5):265-70. PubMed ID: 15960425
[TBL] [Abstract][Full Text] [Related]
2. 3-D QSAR studies of triazolinone based balanced AT1/AT2 receptor antagonists.
Pandya T; Pandey SK; Tiwari M; Chaturved SC; Saxena AK
Bioorg Med Chem; 2001 Feb; 9(2):291-300. PubMed ID: 11249122
[TBL] [Abstract][Full Text] [Related]
3. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
[TBL] [Abstract][Full Text] [Related]
4. Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
Ashton WT; Chang LL; Flanagan KL; Hutchins SM; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ; Chen TB; Faust KA
J Med Chem; 1994 Aug; 37(17):2808-24. PubMed ID: 8064808
[TBL] [Abstract][Full Text] [Related]
5. Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Siegl PK; Kivlighn SD; Lotti VJ; Chang RS
J Med Chem; 1994 Dec; 37(26):4464-78. PubMed ID: 7799397
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
Berellini G; Cruciani G; Mannhold R
J Med Chem; 2005 Jun; 48(13):4389-99. PubMed ID: 15974591
[TBL] [Abstract][Full Text] [Related]
7. Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals.
Lehoux JG; Bird IM; Briere N; Martel D; Ducharme L
Endocrinology; 1997 Dec; 138(12):5238-47. PubMed ID: 9389507
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice.
Brosnihan KB; Hodgin JB; Smithies O; Maeda N; Gallagher P
Exp Physiol; 2008 May; 93(5):658-64. PubMed ID: 18192335
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].
Matsubara H; Mori Y; Masaki H; Inada M
Nihon Rinsho; 1998 Jul; 56(7):1912-8. PubMed ID: 9702075
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
12. QSAR modeling of AT1 receptor antagonists using ANN.
Su Q; Zhou L
J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251
[TBL] [Abstract][Full Text] [Related]
13. Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts.
Ryckwaert F; Colson P; Guillon G; Foëx P
Pharmacol Res; 2005 Jun; 51(6):497-502. PubMed ID: 15829428
[TBL] [Abstract][Full Text] [Related]
14. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
15. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma.
Walsh DA; Hu DE; Wharton J; Catravas JD; Blake DR; Fan TP
Br J Pharmacol; 1997 Apr; 120(7):1302-11. PubMed ID: 9105706
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses.
Peña O; Palumbo A; González-Fernández R; Hernández J; Naftolin F; Avila J
Fertil Steril; 2010 Mar; 93(5):1601-8. PubMed ID: 19524223
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
Hunley TE; Tamura M; Stoneking BJ; Nishimura H; Ichiki T; Inagami T; Kon V
Kidney Int; 2000 Feb; 57(2):570-7. PubMed ID: 10652034
[TBL] [Abstract][Full Text] [Related]
18. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.
Wolf G; Wenzel U; Burns KD; Harris RC; Stahl RA; Thaiss F
Kidney Int; 2002 Jun; 61(6):1986-95. PubMed ID: 12028439
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
D'Amore A; Black MJ; Thomas WG
Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
